Skip to main content
. 2022 Mar 31;12:829705. doi: 10.3389/fonc.2022.829705

Figure 10.

Figure 10

Forest plot of the prognostic value of the expression of USP10 in immune cell subpopulations of patients with PAAD and LIHC. (A) In patients with PAAD, the prognostic benefit of USP10 expression depends on the patients’ different immune cell subsets, according to the forest plot. (B) In patients with LIHC, there was an association between the expression of USP10 and OS for the infiltration of different immune cell subgroups, according to a forest plot. PAAD, pancreatic adenocarcinoma; LIHC, liver hepatocellular carcinoma. OS, overall survival. *P < 0.05.